Helene D. Gayle's most recent trade in Organon & Co. was a trade of 23,904 Phantom Stock done . Disclosure was reported to the exchange on June 13, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Organon & Co. | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 23,904 | 62,702 | - | - | Phantom Stock | |
| Palo Alto | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2024 | 915 | 13,050 (0%) | 0% | 0 | Common Stock | |
| Organon & Co. | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 9,638 | 36,454 | - | - | Phantom Stock | |
| Coca-Cola | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,280 | 61,143 | - | - | Phantom Share Units | |
| Palo Alto | D. Gayle Helene | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2023 | 1,308 | 12,135 (0%) | 0% | 0 | Common Stock | |
| Organon & Co. | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2023 | 10,086 | 25,285 | - | - | Phantom Stock | |
| Coca-Cola | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 3,222 | 55,626 | - | - | Phantom Share Units | |
| Palo Alto | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2022 | 2,157 | 10,827 (0%) | 0% | 0 | Common Stock | |
| Organon & Co. | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2022 | 5,640 | 14,638 | - | - | Phantom Stock | |
| Coca-Cola | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 3,198 | 51,284 | - | - | Phantom Share Units | |
| GoHealth Inc - Ordinary Sh... | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 5,688 | 12,831 | - | - | Deferred Stock Units | |
| Organon & Co. | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 8,772 | 8,772 | - | - | Phantom Stock | |
| GoHealth Inc - Ordinary Sh... | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 7,143 | 7,143 | - | - | Deferred Stock Units | |
| Palo Alto | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 2,890 | 2,890 (0%) | 0% | 0 | Common Stock | |
| Coca-Cola | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 3,787 | 46,649 | - | - | Phantom Stock Units | |
| Colgate-Palmolive | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 76.48 per share. | 01 Apr 2021 | 228 | 21,063 (0%) | 0% | 76.5 | 17,437 | Common Stock |
| Colgate-Palmolive | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 85.10 per share. | 04 Jan 2021 | 205 | 20,747 (0%) | 0% | 85.1 | 17,446 | Common Stock |
| Colgate-Palmolive | Helene D. Gayle | Director | Grant, award, or other acquisition of securities at price $ 76.68 per share. | 01 Oct 2020 | 228 | 20,461 (0%) | 0% | 76.7 | 17,483 | Common Stock |